Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Share News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,753.00
Bid: 0.00
Ask: 1,830.00
Change: 0.00 (0.00%)
Spread: 72.00 (4.096%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,753.00
JMAT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European emissions rules help lift Johnson Matthey profit

Thu, 21st Nov 2013 11:23

* Core H1 profit 212.9 mln pounds vs year-ago 187.9 mln

* Emissions Control Technologies operating profit up 16 pct

* Process Technologies operating profit rises 17 percent

* Sees second half in line, excluding Anglo Platinum impact

* Shares climb over 3 percent

By Clara Ferreira-Marques

LONDON, Nov 21 (Reuters) - Catalyst maker Johnson Matthey beat its own expectations with a 13-percent rise inprofit, lifted by increased car and truck production globally,and tighter European rules on emissions due to come into forcein January.

The British speciality chemicals firm - the world's No. 1maker of catalysts to control car emissions - said underlyingfirst-half profit before tax totalled 212.9 million pounds($344.3 million), at the higher end of analyst expectations andoutperforming the group's own forecast, which had warned of theimpact of summer closures at European car plants.

Much of the jump came from its key Emission ControlTechnologies business, which accounts for more than half thegroup's sales and almost 40 percent of group operating profit.

Underlying operating profit in that division rose 16 percentin the six months to the end of September, thanks to growth insales across regions. That includes long-depressed Europe, wheresales of car catalysts outpaced vehicle production, and where itsaw increased demand for truck catalysts ahead of thelegislation - Euro VI.

Finance Director Robert MacLeod said the group had seencustomers for smaller trucks buying up cheaper Euro V trucksahead of the deadline, and buyers of larger vehicles coming inearly for Euro VI trucks, to benefit from fuel efficiency.

But the impact of "pre-buying" on sales in the second halfof the group's financial year was unclear, MacLeod said.

"We have had a pull forward of orders into this half, orthis calendar year, ahead of the new legislation," he said.

"No one really knows what is going to happen (in 2014). Thetruck fleet in Europe is pretty old too - are some of theseorders just getting the fleet back up to the right age?"

Analysts particularly welcomed the performance in Europe'scar market, where Johnson Matthey appeared to gain market share- beating a dip in production with a 9-percent rise in sales.

"There was a market share beat in the car business inEurope, and on the truck side... 25 percent of their sales wereEuro VI, where revenues are three times as high," analyst AdamCollins at Liberum in London said.

"There is some concern the pre-buy could result in next yearstarting softly, but in the overall scheme of things it doesn'tappear like it will be more than a quarter or so of transition,"he said.

Shares in the group were up 3.3 percent at 1040 GMT at 3,197pence, outperforming a 0.1 percent rise in the FTSE 100.

Johnson Matthey forecast a second half performance broadlyin line with the first six months of its financial year. Thatexcludes the impact of ending long-standing platinum buying andother arrangements with Anglo American Platinum in thenew year, which had included a discount.

Analysts said it could beat that outlook, thanks topre-buying into the coming months and higher margins from EuroVI.

FORMALDEHYDE BOOST

Other divisions also helped, with Process Technologies, thedivision which makes speciality catalysts, reporting sales up 15percent and underlying operating profit up 17 percent, helped bythe acquisition of formaldehyde producer Formox in March.Johnson Matthey's MacLeod said he expected the division couldsee more small-scale deals.

It forecast a second-half performance for the unit "slightlyahead" of the first half.

Precious Metals Products, which refines and recycles, sawcore profit climb by almost a quarter on the year-ago period,which had been hit by operational woes at its Salt Lake Cityrefinery, and by a relatively weak platinum price that held backvolumes at its precious metals refining arm.

Fine Chemicals, a division which makes active pharmaceuticalingredients for the pharmaceutical industry and which JohnsonMatthey has refocused, saw profit tick 1 percent higher, helpedby the sale of ingredients to treat drug addiction and attentiondeficit hyperactivity disorder (ADHD).

More News
10 Apr 2024 08:41

Johnson Matthey and BP win deal for US sustainable aviation fuel plant

(Alliance News) - Johnson Matthey PLC and BP PLC on Wednesday said their technology offering has been selected for use in a sustainable aviation fuel plant being built in the US state of Louisiana.

Read more
10 Apr 2024 07:47

LONDON BRIEFING: Stocks called up ahead of US inflation data

(Alliance News) - Stocks in London are called to open higher, as investors shake off nerves ahead of a key US inflation reading.

Read more
9 Apr 2024 09:51

Berenberg hikes target price on Johnson Matthey

(Sharecast News) - Analysts at Berenberg raised their target price on diversified chemicals business Johnson Matthey from 1,650.0p to 1,800.0p on Tuesday but said the performance of its shares will likely depend on three factors.

Read more
9 Apr 2024 08:54

LONDON BROKER RATINGS: Barclays raises Halma to 'overweight'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
9 Apr 2024 07:39

LONDON BRIEFING: HSBC sells Argentinian arm for USD550 million

(Alliance News) - Stocks in London are called to open lower on Tuesday, as investors nervously look ahead to US inflation data and the European Central Bank's latest interest rate decision.

Read more
25 Mar 2024 10:19

LONDON BROKER RATINGS: SocGen raises Sage; Numis cuts Virgin Money

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
20 Mar 2024 16:54

LONDON MARKET CLOSE: FTSE 100 treads water while Kering weighs on CAC

(Alliance News) - London's FTSE 100 finished the day largely as it started it, enduring an uninspiring session on Wednesday, with the latest Federal Reserve decision about an hour away.

Read more
20 Mar 2024 16:53

London close: Stocks mixed ahead of Fed, BoE decisions

(Sharecast News) - London markets closed with a mixed but little-changed performance on Wednesday, as investors digested a larger-than-expected slowdown in UK inflation.

Read more
20 Mar 2024 11:49

LONDON MARKET MIDDAY: Pre-Fed rate nerves push FTSE 100 in red

(Alliance News) - The FTSE 100 was in the red on Wednesday at midday, as relief from cooling UK inflation was not enough to shake off nerves ahead of the latest US Federal Reserve interest rate decision.

Read more
20 Mar 2024 08:45

LONDON MARKET OPEN: UK inflation cooler than expected ahead of BoE

(Alliance News) - The FTSE 100 in London opened lower on Wednesday morning, with cooler-than-expected inflation doing little to shake off pre-US Federal rate nerves.

Read more
20 Mar 2024 08:32

Johnson Matthey sells medical device components arm for USD700 million

(Alliance News) - Johnson Matthey PLC on Wednesday said it has agreed to sell its Medical Device Components business to Montagu Private Equity LLP, with the proceeds to fund a share buyback.

Read more
20 Mar 2024 07:40

LONDON BRIEFING: UK inflation cools to 3.4% in February; Eyes on Fed

(Alliance News) - Stocks in London are expected to open slightly lower on Wednesday, as investors digest some cooler-than-expected inflation in the UK and look ahead to the latest US interest rate decision.

Read more
20 Mar 2024 07:08

Johnson Matthey sells medical parts unit for $700m

(Sharecast News) - Johnson Matthey is selling its medical device components business to Montagu Private Equity for $700m (£550m), the company said on Wednesday.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
12 Dec 2023 13:01

Gelion makes "solid progress" amid acquisitions and cost saving

(Alliance News) - Gelion PLC said it had made "significant advancements" towards profit in its recently ended financial year, crediting progress to cost-cutting measures and strategic acquisitions.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.